BullHunter

Part-time investor, my tweets are opinions only. I mostly reffer to the charts for my picks. Presently focusing on Gold and Uranium sector.

[Zacks SCR @ZacksSmallCap]

$PMN.TO: More Support for Toxic Oligomers @ProMISinc https://t.co/fyjQk9UAlj - by @vanjohn10

[Alphadogspartan @alphadogspartan]

https://t.co/5Ci1yMctrH
ProMIS Neurosciences Issues White Paper Entitled 'State of the Art at AAIC 2018' $pmn.to

[CFN Media @CFNMediaNews]

$EMH $EMHTF | @EmeraldHealthHQ will supply its high-quality #cannabis products to the #BritishColumbia Liquor Distribution Branch to serve the adult-use market throughout the province.
[Sponsored Content: https://t.co/3TiqCPCqmX] #cannabis #investing
https://t.co/VgWXYGq3rS

[tim winans @echobbbb]

iQIYI Reveals Online Movie Shared Revenue Figures in First Half of 2018 https://t.co/qarvEYwTpF via @YahooFinance...@traderstewie

[Aben Gold Corp. @AbenGoldCorp]

MotherlodeTV on Aben Resources: Deep in BC’s Golden Triangle: https://t.co/2WUIbwTayM via @jaycurrie $ABN.v $ABNAF #Gold #GoldMining

[Gerardo Del Real @RSDigest]

RSD Weekly Recap: Aben Resources (TSX-V: ABN), Chakana Copper (TSX-V: PERU) $ABN.V $PERU.V https://t.co/kn25uNuxRp

[Antibe Therapeutics @AntibeThera]

We are pleased to announce the secondary endpoint data from the recent Phase 2B safety study for ATB-346. The data are consistent with the primary endpoint data, showing unequivocal superiority over naproxen
https://t.co/XIr5HJWLKu $ATE.V $ATBPF #saferNSAID

[Antibe Therapeutics @AntibeThera]

We're pleased to announce the results of our annual general and special meeting held on Monday, June 25th https://t.co/rFNuZsCCFP $ATE.V $ATBPF

[Antibe Therapeutics @AntibeThera]

In light of recent research showing that ordinary NSAIDs can impair bone healing https://t.co/uzkTQhGLd5, we thought you'd like to see some research from 2015, indicating that our lead drug has promise in aiding bone regeneration https://t.co/LIULVswv1Y #saferNSAID $ATE.V $ATBPF

[Antibe Therapeutics @AntibeThera]

Congratulations to @AntibeCSO and his colleagues on research demonstrating the therapeutic potential of ATB-352 (one of our pipeline drugs) in addressing periodontal disease, the most common cause of tooth loss -- published in @ELSpharma https://t.co/CefVn2ktRE $ATE.V $ATBPF

[Antibe Therapeutics @AntibeThera]

This breakthrough in #IBD and Crohn's Disease at @UCalgary involves our drugs and drug delivery platform https://t.co/cjlP2XwbUV … @UofC_Science #Colitis

[Antibe Therapeutics @AntibeThera]

This breakthrough in #IBD and Crohn's Disease at @UCalgary involves our drugs and drug delivery platform:
https://t.co/cjlP2XeB3n @UofC_Science #Crohns #Colitis $ATE.V $ATBPF

[Antibe Therapeutics @AntibeThera]

If you're in Brazil on Thurs, join @AntibeCSO at INFLAMMA IV for his talk on the promise of Antibe drugs in the opioid crisis -- at the Center for Research in Inflammatory Diseases, a short flight from Rio de Janeiro or Sao Paulo https://t.co/htZXlVYtuy $ATE.V $ATBPF #saferNSAID

[Antibe Therapeutics @AntibeThera]

In Boston today? Join us at #BIO2018, 2018's largest biopharma partnering event. We are engaging multinational pharma firms to secure strategic licensing deals for the major markets, while we continue to advance on-going discussions for smaller markets $ATE.V $ATBPF #saferNSAID

[Bonterra Resources (TSXV: BTR | OTCQX: BONXF) @BonterraGold]

Bonterra Resources ( TSX-V: $BTR.v , OTCQX: $BONXF ) Management Team has Extensive Experience in Technical and Capital Markets. Learn more about the Bonterra team here [ https://t.co/S99pa9CFBN ] #mining

[John Quakes @quakes99]

Looking for #Stocks Trading Alerts? Tune your dial to @SetYourStop for highlighted opportunities.💡Tonight he's pointing out Fission #Uranium #TSX: $FCU as one to watch, moving up on high volume. 🔊

NEWS, BREAKOUTS, MOMENTUM PLAYS, & BOTTOMS – MAY 3, 2018 https://t.co/0GPmEogZc7

[John Quakes @quakes99]

Kazakhstan has committed to 3-year #uranium supply cut at 20% below contracted levels = no more that 23,000tU (~60M lbs/yr) thru 2020. Government also mandating Kazatomprom IPO this year. 💰Further, they're setting up #Uranium Fund to sequester #U3O8 from Spot Market.⚛️⤴️

[John Quakes @quakes99]

#Russia has ordered Rosatom to impose a temporary ban on signing any new #nuclear & #uranium contracts with US & other EU countries supporting US #sanctions. Ban came into effect on April 13. Russian Parliament votes on making it permanent ban on May 15.😲 https://t.co/8UTQQa11PK